Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
A brand new vaccine exhibits encouraging early outcomes as a possible off-the-shelf remedy for sure sufferers with pancreatic or colorectal most cancers, in...
There have been many key updates for the remedy of sufferers with lung most cancers, however maybe an important—and practice-changing— growth is the...
